Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.009 USD | +28.57% | -.--% | -10.00% |
Business Summary
Number of employees: 3
Sales per Business
USD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Natural Compounds and Pharmaceutical Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -40.43% |
Sales per region
USD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -40.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rose Perri
CEO | Chief Executive Officer | 55 | 14/01/15 |
William Abajian
PSD | President | 66 | 31/05/16 |
Ishaan Sundar
CTO | Chief Tech/Sci/R&D Officer | - | 11/04/17 |
Anna Gluskin
BRD | Director/Board Member | 68 | 21/05/12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anna Gluskin
BRD | Director/Board Member | 68 | 21/05/12 |
Rose Perri
CEO | Chief Executive Officer | 55 | 14/01/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 717,257,377 | 717,257,377 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-10.00% | 9.52M | |
+40.34% | 723B | |
+34.28% | 595B | |
-3.73% | 369B | |
+20.43% | 332B | |
+3.11% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.33% | 168B |
- Stock Market
- Equities
- ETBI Stock
- Company Eastgate Biotech Corp.